Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 7 | 2024 | 82 | 2.230 |
Why?
|
| Gastroscopy | 5 | 2015 | 100 | 1.310 |
Why?
|
| Endoscopy, Gastrointestinal | 7 | 2024 | 244 | 1.020 |
Why?
|
| Endosonography | 7 | 2024 | 81 | 0.870 |
Why?
|
| Endoscopic Mucosal Resection | 2 | 2023 | 74 | 0.630 |
Why?
|
| Gastric Fistula | 2 | 2016 | 5 | 0.630 |
Why?
|
| Stomach | 3 | 2015 | 271 | 0.610 |
Why?
|
| Weight Loss | 2 | 2019 | 516 | 0.590 |
Why?
|
| Suture Techniques | 3 | 2016 | 202 | 0.580 |
Why?
|
| Sutures | 2 | 2015 | 67 | 0.580 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 4 | 2024 | 81 | 0.560 |
Why?
|
| Choledochostomy | 2 | 2024 | 5 | 0.560 |
Why?
|
| Cholestasis | 3 | 2024 | 158 | 0.520 |
Why?
|
| Weight Gain | 1 | 2019 | 414 | 0.520 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 97 | 0.490 |
Why?
|
| Metabolomics | 1 | 2019 | 456 | 0.490 |
Why?
|
| Duodenal Diseases | 1 | 2015 | 34 | 0.490 |
Why?
|
| Omentum | 1 | 2015 | 48 | 0.480 |
Why?
|
| Intestinal Obstruction | 1 | 2015 | 94 | 0.450 |
Why?
|
| Reoperation | 3 | 2016 | 866 | 0.440 |
Why?
|
| Postoperative Complications | 2 | 2015 | 3227 | 0.410 |
Why?
|
| Pancreatitis, Chronic | 2 | 2024 | 76 | 0.400 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 3 | 2024 | 32 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 734 | 0.290 |
Why?
|
| Obesity | 1 | 2019 | 2416 | 0.280 |
Why?
|
| Gastrostomy | 2 | 2024 | 92 | 0.270 |
Why?
|
| Nerve Block | 2 | 2024 | 68 | 0.260 |
Why?
|
| Clinical Competence | 3 | 2019 | 1066 | 0.260 |
Why?
|
| Endoscopy, Digestive System | 2 | 2019 | 156 | 0.250 |
Why?
|
| Learning Curve | 3 | 2019 | 57 | 0.220 |
Why?
|
| Oncolytic Viruses | 1 | 2024 | 77 | 0.210 |
Why?
|
| Drainage | 1 | 2024 | 265 | 0.200 |
Why?
|
| Pancreatic Diseases | 1 | 2022 | 40 | 0.200 |
Why?
|
| Enteral Nutrition | 1 | 2024 | 270 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2017 | 506 | 0.190 |
Why?
|
| Needles | 2 | 2024 | 53 | 0.190 |
Why?
|
| Thrombocytopenia | 1 | 2024 | 235 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2024 | 337 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 327 | 0.180 |
Why?
|
| Anemia | 1 | 2024 | 351 | 0.160 |
Why?
|
| Humans | 27 | 2024 | 133937 | 0.160 |
Why?
|
| Ultrasonography, Interventional | 2 | 2024 | 205 | 0.160 |
Why?
|
| Adult | 8 | 2022 | 31949 | 0.160 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2018 | 9 | 0.150 |
Why?
|
| Time | 1 | 2018 | 100 | 0.150 |
Why?
|
| Prospective Studies | 5 | 2023 | 6664 | 0.140 |
Why?
|
| Diet, Reducing | 1 | 2018 | 93 | 0.140 |
Why?
|
| Serum Amyloid A Protein | 1 | 2017 | 44 | 0.140 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2017 | 9 | 0.140 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2017 | 13 | 0.140 |
Why?
|
| Electrosurgery | 1 | 2017 | 16 | 0.130 |
Why?
|
| Operative Time | 2 | 2016 | 183 | 0.130 |
Why?
|
| Mitomycin | 1 | 2017 | 53 | 0.130 |
Why?
|
| Esophageal Stenosis | 1 | 2017 | 45 | 0.130 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 2016 | 9 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 1070 | 0.130 |
Why?
|
| Intestinal Fistula | 1 | 2016 | 28 | 0.130 |
Why?
|
| Interleukins | 2 | 2017 | 132 | 0.130 |
Why?
|
| Cutaneous Fistula | 1 | 2016 | 23 | 0.130 |
Why?
|
| Gloves, Protective | 1 | 2015 | 4 | 0.130 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2015 | 15 | 0.120 |
Why?
|
| Gastroenterology | 1 | 2019 | 211 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 212 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 314 | 0.120 |
Why?
|
| Celiac Plexus | 2 | 2024 | 4 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2019 | 1484 | 0.120 |
Why?
|
| Endoscopy | 1 | 2017 | 291 | 0.110 |
Why?
|
| Simulation Training | 1 | 2017 | 146 | 0.110 |
Why?
|
| Foreign Bodies | 1 | 2015 | 109 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2014 | 58 | 0.110 |
Why?
|
| Nucleotides | 1 | 2014 | 94 | 0.110 |
Why?
|
| Dissection | 1 | 2014 | 59 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 560 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 142 | 0.110 |
Why?
|
| Female | 10 | 2024 | 71682 | 0.100 |
Why?
|
| Stents | 3 | 2024 | 877 | 0.090 |
Why?
|
| Microbiota | 2 | 2014 | 443 | 0.090 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 218 | 0.090 |
Why?
|
| Amino Acids | 1 | 2014 | 688 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2015 | 1254 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 383 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2014 | 287 | 0.090 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2008 | 68 | 0.090 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 491 | 0.090 |
Why?
|
| Middle Aged | 6 | 2022 | 29409 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 822 | 0.080 |
Why?
|
| Male | 7 | 2024 | 65902 | 0.080 |
Why?
|
| Colonoscopy | 1 | 2011 | 250 | 0.080 |
Why?
|
| G2 Phase | 1 | 2008 | 45 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 271 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 7212 | 0.070 |
Why?
|
| Cell Division | 1 | 2008 | 774 | 0.060 |
Why?
|
| Aged | 3 | 2019 | 21746 | 0.060 |
Why?
|
| Intestinal Mucosa | 3 | 2017 | 815 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2008 | 688 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2006 | 191 | 0.060 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2024 | 8 | 0.060 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2024 | 15 | 0.060 |
Why?
|
| Pancreatic Ducts | 1 | 2024 | 21 | 0.060 |
Why?
|
| Th17 Cells | 2 | 2017 | 101 | 0.060 |
Why?
|
| Calculi | 1 | 2024 | 15 | 0.060 |
Why?
|
| Hernia, Hiatal | 1 | 2024 | 61 | 0.060 |
Why?
|
| Cholecystitis, Acute | 1 | 2024 | 18 | 0.060 |
Why?
|
| Biliary Tract Diseases | 1 | 2024 | 37 | 0.060 |
Why?
|
| Lithotripsy | 1 | 2024 | 27 | 0.060 |
Why?
|
| Fundoplication | 1 | 2024 | 71 | 0.060 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2024 | 21 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2006 | 486 | 0.050 |
Why?
|
| Albumins | 1 | 2024 | 99 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2024 | 103 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2024 | 242 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2024 | 143 | 0.050 |
Why?
|
| Colon | 2 | 2017 | 378 | 0.050 |
Why?
|
| Recurrence | 2 | 2017 | 1471 | 0.050 |
Why?
|
| Deglutition Disorders | 1 | 2024 | 147 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 314 | 0.050 |
Why?
|
| Rectum | 1 | 2023 | 113 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 201 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2024 | 284 | 0.050 |
Why?
|
| Neoplasms | 1 | 2017 | 3027 | 0.050 |
Why?
|
| Macrophages | 1 | 2006 | 704 | 0.050 |
Why?
|
| Life Style | 1 | 2024 | 454 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2023 | 17488 | 0.050 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 285 | 0.050 |
Why?
|
| Swine | 2 | 2016 | 1216 | 0.050 |
Why?
|
| Pancreas | 1 | 2022 | 233 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 5511 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 777 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2024 | 599 | 0.040 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2019 | 12 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 690 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2024 | 733 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2018 | 73 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 104 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 90 | 0.040 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 91 | 0.030 |
Why?
|
| Portal Pressure | 1 | 2016 | 5 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2017 | 144 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 130 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1353 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 217 | 0.030 |
Why?
|
| Hepatic Veins | 1 | 2016 | 24 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 233 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2018 | 317 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 266 | 0.030 |
Why?
|
| Workload | 1 | 2016 | 151 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 832 | 0.030 |
Why?
|
| Nitriles | 1 | 2015 | 155 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 613 | 0.030 |
Why?
|
| Animals | 5 | 2018 | 36387 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 971 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2017 | 338 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2017 | 701 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 239 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1304 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 815 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1489 | 0.030 |
Why?
|
| Metagenomics | 1 | 2014 | 109 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 392 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2014 | 104 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1315 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 197 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 1614 | 0.020 |
Why?
|
| Models, Animal | 1 | 2014 | 483 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2013 | 215 | 0.020 |
Why?
|
| Cell Line | 2 | 2008 | 2836 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 247 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2163 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1052 | 0.020 |
Why?
|
| Transcriptome | 1 | 2018 | 1127 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1977 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 724 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2011 | 65 | 0.020 |
Why?
|
| Liver | 1 | 2018 | 1875 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 486 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3639 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 371 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4822 | 0.020 |
Why?
|
| Prenylation | 1 | 2008 | 2 | 0.020 |
Why?
|
| Protein Prenylation | 1 | 2008 | 10 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2008 | 16 | 0.020 |
Why?
|
| Proline | 1 | 2008 | 80 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 13013 | 0.020 |
Why?
|
| Opsonin Proteins | 1 | 2006 | 20 | 0.020 |
Why?
|
| Ionomycin | 1 | 2006 | 19 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 630 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 2006 | 33 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2006 | 26 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2006 | 51 | 0.020 |
Why?
|
| Phagosomes | 1 | 2006 | 38 | 0.020 |
Why?
|
| Molecular Probes | 1 | 2006 | 31 | 0.020 |
Why?
|
| Static Electricity | 1 | 2006 | 47 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 66 | 0.020 |
Why?
|
| Mice | 2 | 2018 | 18909 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1599 | 0.020 |
Why?
|
| Phospholipids | 1 | 2006 | 113 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2006 | 115 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 586 | 0.020 |
Why?
|
| ras Proteins | 1 | 2006 | 146 | 0.020 |
Why?
|
| Liposomes | 1 | 2006 | 207 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 317 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 270 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 801 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2781 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 823 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3967 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 859 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1146 | 0.010 |
Why?
|
| Child | 1 | 2017 | 25739 | 0.010 |
Why?
|